A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Examine the Effect of Betahistine on Body Weight in Obese Female Subjects.
Phase of Trial: Phase II
Latest Information Update: 24 May 2012
At a glance
- Drugs Betahistine (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors OBEcure
- 10 Jun 2017 Biomarkers information updated
- 08 May 2009 Planned number of patients changed from 180 to 187 as reported by ClinicalTrials.gov.
- 20 Jan 2009 Status changed from recruiting to active, no longer recruiting, according to an Obecure media release. Results are expected by the end of Q2 2009.